Aim: We have shown that a combination of ligustrazine and berberine produces more
effective inhibition on platelet activation and inflammatory reactions in rat acute myocardial …

… In this study, we showed that pre-treatment of MSCs with a combination of GFs (FGF-2 +
IGF-1 + BMP-2) enhanced the expression of cardiac transcription factors and that these primed …

… the combination [3-11]. Based on this possible pharmacodynamic effect, we evaluated the
cardiac safety … Pretreatment characteristics (Table 1) were similar between the treatment arms. …

… Since exosomes and the combinatorially pretreated MSCs therapy achieved elevated cardiac
function, we further evaluated the infarct size and collagen area. The Exo + MSC H , Exo + …

… These patients have few surgical options for treatment because they have a combination
of both dilated and restrictive cardiomyopathies, and make poor heart transplant candidates …

… flow, can be restored after prolonged cardiac arrest by administering an adrenergic
vasopressor … with adverse cardiac effects that can be minimized by pretreatment with concurrent …

… pretreatment group at 0, 1, and 3 h, indicating that the adenosine pretreatment group had a
better cardiac function. The … has a significant myocardial protective effect in combination with …

… treatment improved the survival of MSCs, and ATV pretreated MSCs ( ATV- MSCs) exhibited
… whether combined treatment with ATV and ATV- MSCs enhances cardiac repair and …

… group demonstrated poor cardiac function and decreased p-… significant improvement in
cardiac function and increased … pretreatment in AMI can effectively improve cardiac function …

… Again, TMZ pretreatment significantly reduced the apoptotic rate and also the … pretreatment
could significantly inhibit CME-induced myocardial apoptosis and improve cardiac function, …